APN technology | CBTF linker | Publication in Bioconjugate Chemistry

An article highlighting the use of Syndivia's CBTF linker (APN technology) for producing stable antibody conjugates has been published in Bioconjugate Chemistry. In this publication, the authors use the new CBTF-based approach for the preparation of bioconjugates and benchmark it against the commonly applied SMCC linker.
The publication can be downloaded on the ACS website: http://pubs.acs.org/doi/abs/10.1021/bc500610g